Review of the effect of dairy products on non-lipid risk factors for cardiovascular disease

Journal of the American College of Nutrition

Volumn 27, Issue 6, 2008, Pages 741S-746S

  Lamarche, Benoı̂t ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Dairy foods; Diabetes; Hypertension; Inflammation; Obesity

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; CALCIUM; CASEIN; INSULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE; BODY WEIGHT; CALCIUM INTAKE; CALORIC INTAKE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DAIRY PRODUCT; DIET SUPPLEMENTATION; DIET THERAPY; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FOOD INTAKE; FRUIT; GENE EXPRESSION; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPID STORAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; REVIEW; RISK FACTOR; SODIUM INTAKE; VEGETABLE; WAIST CIRCUMFERENCE; WHEY; DRUG EFFECT; FAT INTAKE;

BODY WEIGHT; CARDIOVASCULAR DISEASES; DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIETARY FATS; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 61449142597     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2008.10719752     Document Type: Article

References (52)

1. Hu FB, Stampfer MJ, Manson JE, Ascherio A, Colditz GA, Speizer FE, Hennekens CH, Willett WC: Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr 70:1001–1008, 1999.
2. Elwood PC, Pickering JE, Hughes J, Fehily AM, Ness AR: Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 58:718–724, 2004.
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106:3143–3421, 2002.
4. Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallee M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ: The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 24:465–475, 2008.
5. McCarron DA, Morris CD, Henry HJ, Stanton JL: Blood pressure and nutrient intake in the United States. Science 224:1392–1398, 1984.
6. Garcia-Palmieri MR, Costas R, Jr., Cruz-Vidal M, Sorlie PD, Tillotson J, Havlik RJ: Milk consumption, calcium intake, and decreased hypertension in Puerto Rico. Puerto Rico Heart Health Program study. Hypertension 6:322–328, 1984.
7. Trevisan M, Krogh V, Farinaro E, Panico S, Mancini M: Calciumrich foods and blood pressure: findings from the Italian National Research Council Study (the Nine Communities Study). Am J Epidemiol 127:1155–1163, 1988.
8. Wang L, Manson JE, Buring JE, Lee IM, Sesso HD: Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 51:1073–1079, 2008.
9. Abbott RD, Curb JD, Rodriguez BL, Sharp DS, Burchfiel CM, Yano K: Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men. The Honolulu Heart Program. Stroke 27:813–818, 1996.
10. Iso H, Stampfer MJ, Manson JE, Rexrode K, Hennekens CH, Colditz GA, Speizer FE, Willett WC: Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 30:1772–1779, 1999.
11. Ascherio A, Rimm EB, Hernan MA, Giovannucci EL, Kawachi I, Stampfer MJ, Willett WC: Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 98:1198–1204, 1998.
12. Barr SI, McCarron DA, Heaney RP, Dawson-Hughes B, Berga SL, Stern JS, Oparil S: Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 100:810–817, 2000.
13. Appel U, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N, Simons-Morton D, McCullough M, Swain J, Steele P, Evans MA, Miller ER, Harsha DW, The DASH Collaborative Research Group: A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336:1117, 1997.
14. Craddick SR, Elmer PJ, Obarzanek E, Vollmer WM, Svetkey LP, Swain MC: The DASH diet and blood pressure. Curr Atheroscler Rep 5:484–491, 2003.
15. McCarron DA, Reusser ME: Finding consensus in the dietary calcium-blood pressure debate. J Am Coll Nutr 18:398S–405S, 1999.
16. Zemel MB: Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 20:428S–435S, 2001.
17. Sacks FM, Willett WC, Smith A, Brown LE, Rosner B, Moore TJ: Effect on blood pressure of potassium, calcium, and magnesium in women with low habitual intake. Hypertension 31:131–138, 1998.
18. FitzGerald RJ, Meisel H: Milk protein-derived peptide inhibitors of angiotensin-I–converting enzyme. Br J Nutr 84 Suppl 1:S33–S37, 2000.
19. Maes W, Van Camp J, Vermeirssen V, Hemeryck M, Ketelslegers JM, Schrezenmeir J, Van Oostveldt P, Huyghebaert A: Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regul Pept 118:105–109, 2004.
20. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135–1143, 2002.
21. Ridker PM, Silvertown JD: Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 79:1544–1551, 2008.
22. Ridker PM, Cook N: Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham risk scores. Circulation 109:1955–1951, 2004.
23. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:E20–E28, 1999.
24. Libby P, Simon DI: Inflammation and thrombosis-The clot thickens. Circulation 103:1718–1720, 2001.
25. Sardo MA, Campo S, Mandraffino G, Saitta C, Bonaiuto A, Castaldo M, Cinquegrani M, Pizzimenti G, Saitta A: Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. Clin Chem 54:814–823, 2008.
26. Zemel MB, Sun X: Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr 138:1047–1052, 2008.
27. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76–79, 2003.
28. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–1200, 2001.
29. Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D’Agostino RB, Sr., Wilson PW, Savage PJ: Trends in cardiovascular complications of diabetes. JAMA 292:2495–2499, 2004.
30. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335–342, 2004.
31. Despres JP, Cartier A, Cote M, Arsenault BJ: The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Ann Med 40:514–523, 2008.
32. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 30:162–172, 2007.
33. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403, 2002.
34. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350, 2001.
35. Pittas AG, Lau J, Hu FB, Dawson-Hughes B: The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 92:2017–2029, 2007.
36. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389, 1994.
37. Sacks FM, Moye LA, Davis BR, Cole TG, Rouleau JL, Nash DT, Pfeffer MA, Braunwald E: Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation 97:1446–1452, 1998.
38. Lamarche B, Lewis GF: Atherosclerosis prevention for the next decade: risk assessment beyond LDL cholesterol. Can J Cardiol 14:841–851, 1998.
39. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049, 2008.
40. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults-Findings from the Third National Health and Nutrition Examination Survey. JAMA 287:356–359, 2002.
41. Astrup A: How to maintain a healthy body weight. Int J Vitam Nutr Res 76:208–215, 2006.
42. Lanou AJ, Barnard ND: Dairy and weight loss hypothesis: an evaluation of the clinical trials. Nutr Rev 66:272–279, 2008.
43. Zemel MB: Dairy and weight loss hypothesis. Nutr Rev 66:542–543, 2008.
44. Tremblay A: Dairy and weight loss hypothesis. Nutr Rev 66:544–545, 2008.
45. Lanou AJ, Barnard ND: Authors’ reply. Nutr Rev 66:546–547, 2008.
46. Zemel MB: The role of dairy foods in weight management. J Am Coll Nutr 24:537S–546S, 2005.
47. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. FASEB J 14:1132–1138, 2000.
48. Beydoun MA, Gary TL, Caballero BH, Lawrence RS, Cheskin LJ, Wang Y: Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 87:1914–1925, 2008.
49. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F: Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr 82:523–530, 2005.
50. Liu S, Song Y, Ford ES, Manson JE, Buring JE, Ridker PM: Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 28: 2926–2932, 2005.
51. Pereira MA, Jacobs DR, Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS: Dairy Consumption, Obesity, and the Insulin Resistance Syndrome in Young Adults: The CARDIA Study. JAMA 287:2081, 2002.
52. Snijder MB, van Dam RM, Stehouwer CD, Hiddink GJ, Heine RJ, Dekker JM: A prospective study of dairy consumption in relation to changes in metabolic risk factors: the Hoorn Study. Obesity (Silver Spring) 16:706–709, 2008.